These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 26955620)

  • 1. Phenotypic Characterization of a Novel Virulence-Factor Deletion Strain of Burkholderia mallei That Provides Partial Protection against Inhalational Glanders in Mice.
    Bozue JA; Chaudhury S; Amemiya K; Chua J; Cote CK; Toothman RG; Dankmeyer JL; Klimko CP; Wilhelmsen CL; Raymond JW; Zavaljevski N; Reifman J; Wallqvist A
    Front Cell Infect Microbiol; 2016; 6():21. PubMed ID: 26955620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies against
    Zimmerman SM; Dyke JS; Jelesijevic TP; Michel F; Lafontaine ER; Hogan RJ
    Infect Immun; 2017 Aug; 85(8):. PubMed ID: 28507073
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of Burkholderia mallei ΔtonB Δhcp1 (CLH001) as a live attenuated vaccine in murine models of glanders and melioidosis.
    Khakhum N; Bharaj P; Myers JN; Tapia D; Walker DH; Endsley JJ; Torres AG
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007578. PubMed ID: 31306423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aerogenic vaccination with a Burkholderia mallei auxotroph protects against aerosol-initiated glanders in mice.
    Ulrich RL; Amemiya K; Waag DM; Roy CJ; DeShazer D
    Vaccine; 2005 Mar; 23(16):1986-92. PubMed ID: 15734072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burkholderia mallei CLH001 Attenuated Vaccine Strain Is Immunogenic and Protects against Acute Respiratory Glanders.
    Hatcher CL; Mott TM; Muruato LA; Sbrana E; Torres AG
    Infect Immun; 2016 Aug; 84(8):2345-54. PubMed ID: 27271739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Peptidoglycan-associated lipoprotein Pal contributes to the virulence of
    Dyke JS; Huertas-Diaz MC; Michel F; Holladay NE; Hogan RJ; He B; Lafontaine ER
    Virulence; 2020 Dec; 11(1):1024-1040. PubMed ID: 32799724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A disruption of ctpA encoding carboxy-terminal protease attenuates Burkholderia mallei and induces partial protection in CD1 mice.
    Bandara AB; DeShazer D; Inzana TJ; Sriranganathan N; Schurig GG; Boyle SM
    Microb Pathog; 2008 Sep; 45(3):207-16. PubMed ID: 18614331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Autotransporter BpaB Contributes to the Virulence of Burkholderia mallei in an Aerosol Model of Infection.
    Zimmerman SM; Michel F; Hogan RJ; Lafontaine ER
    PLoS One; 2015; 10(5):e0126437. PubMed ID: 25993100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of a safe, reproducible, and rapid aerosol delivery method to study infection by Burkholderia pseudomallei and Burkholderia mallei in mice.
    Lafontaine ER; Zimmerman SM; Shaffer TL; Michel F; Gao X; Hogan RJ
    PLoS One; 2013; 8(10):e76804. PubMed ID: 24098563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Immunohistochemistry to Demonstrate In Vivo Expression of the Burkholderia mallei Virulence Factor BpaB During Experimental Glanders.
    Zimmerman SM; Long ME; Dyke JS; Jelesijevic TP; Michel F; Lafontaine ER; Hogan RJ
    Vet Pathol; 2018 Mar; 55(2):258-267. PubMed ID: 29145795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders.
    Moustafa DA; Scarff JM; Garcia PP; Cassidy SK; DiGiandomenico A; Waag DM; Inzana TJ; Goldberg JB
    PLoS One; 2015; 10(7):e0132032. PubMed ID: 26148026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Burkholderia mallei and pseudomallei vaccines.
    Silva EB; Dow SW
    Front Cell Infect Microbiol; 2013; 3():10. PubMed ID: 23508691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies passively protect BALB/c mice against Burkholderia mallei aerosol challenge.
    Treviño SR; Permenter AR; England MJ; Parthasarathy N; Gibbs PH; Waag DM; Chanh TC
    Infect Immun; 2006 Mar; 74(3):1958-61. PubMed ID: 16495574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of non-human primates against glanders with a gold nanoparticle glycoconjugate vaccine.
    Torres AG; Gregory AE; Hatcher CL; Vinet-Oliphant H; Morici LA; Titball RW; Roy CJ
    Vaccine; 2015 Jan; 33(5):686-92. PubMed ID: 25533326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innate immune response to Burkholderia mallei.
    Saikh KU; Mott TM
    Curr Opin Infect Dis; 2017 Jun; 30(3):297-302. PubMed ID: 28177960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective efficacy of heat-inactivated B. thailandensis, B. mallei or B. pseudomallei against experimental melioidosis and glanders.
    Sarkar-Tyson M; Smither SJ; Harding SV; Atkins TP; Titball RW
    Vaccine; 2009 Jul; 27(33):4447-51. PubMed ID: 19490962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Burkholderia mallei virulence factors linked to specific host-pathogen protein interactions.
    Memisević V; Zavaljevski N; Pieper R; Rajagopala SV; Kwon K; Townsend K; Yu C; Yu X; DeShazer D; Reifman J; Wallqvist A
    Mol Cell Proteomics; 2013 Nov; 12(11):3036-51. PubMed ID: 23800426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the murine macrophage response to infection with virulent and avirulent Burkholderia species.
    Chiang CY; Ulrich RL; Ulrich MP; Eaton B; Ojeda JF; Lane DJ; Kota KP; Kenny TA; Ladner JT; Dickson SP; Kuehl K; Raychaudhuri R; Sun M; Bavari S; Wolcott MJ; Covell D; Panchal RG
    BMC Microbiol; 2015 Nov; 15():259. PubMed ID: 26545875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burkholderia pseudomallei Δ
    Khakhum N; Bharaj P; Myers JN; Tapia D; Kilgore PB; Ross BN; Walker DH; Endsley JJ; Torres AG
    mSphere; 2019 Jan; 4(1):. PubMed ID: 30602524
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of the Burkholderia mallei tonB Mutant and Its Potential as a Backbone Strain for Vaccine Development.
    Mott TM; Vijayakumar S; Sbrana E; Endsley JJ; Torres AG
    PLoS Negl Trop Dis; 2015; 9(6):e0003863. PubMed ID: 26114445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.